In the present study, we confirmed that the mRNA expression levels of METTL3 were increased in HCC tissues than in normal tissues from TCGA and our data, and the higher mRNA expression levels of METTL3 were associated with poorer OS of HCC patients. The gene discussed is METTL3; the disease is hepatocellular carcinoma.